Mutations in EFL1, an SBDS partner, are associated with infantile pancytopenia, exocrine pancreatic insufficiency and skeletal anomalies in aShwachman-Diamond like syndrome. Issue 8 (22nd March 2017)

• Record Type: Journal Article
• Authors: Stepensky, Polina; Chacón-Flores, Montserrat; Kim, Katherine H; Abuzaitoun, Omar; Bautista-Santos, Arnulfo; Simanovsky, Natalia; Siliqi, Dritan; Altamura, Davide; Méndez-Godoy, Alfonso; Gijsbers, Abril; Naser Eddin, Adeeb; Dor, Talia; Charrow, Joel; Sánchez-Puig, Nuria; Elpeleg, Orly
• Is Part Of: Journal of medical genetics. Volume 54:Issue 8(2017)
• Page Start: 558
• Page End: 566
• Publication Date: 2017-03-22
• Subjects: Ribosome -- exocrine pancreatic insufficiency -- pancytopenia -- Shwachman-Diamond syndrome; Medical genetics -- Periodicals; 616.042
• DOI: 10.1136/jmedgenet-2016-104366
• Languages: English
• ISSNs: 1468-6244

Abstract

Abstract : Background: For the final step of the maturation of the ribosome, the nascent 40S and 60S subunits are exported from the nucleus to the cell cytoplasm. To prevent premature association of these ribosomal subunits, eukaryotic initiation factor 6 (eIF6) binds the 60S subunit within the nucleus. Its release in the cytoplasm requires the interaction of EFL1 and SDBS proteins. In Shwachman-Diamond syndrome (SDS), a defective SDBS protein prevents eIF6 eviction, inhibiting its recycle to the nucleus and subsequent formation of the active 80S ribosome. Objective: This study aims to identify the molecular basis of an SDS-like disease, manifested by pancytopenia, exocrine pancreatic insufficiency and skeletal abnormalities in six patients from three unrelated families. Methods: Whole exome analysis was used for mutation identification. Fluorescence microscopy studies assessed the localisation of Tif6-GFP, the yeast eIF6 homologue, in yeast WT and mutant cells. Human and yeast EFL1 proteins, WT and mutants, were expressed in Saccharomyces cerevisiae BCY123 strain, and circular dichroism and small-angle X-ray scattering were used to assess the folding and flexibility of these proteins. Green malachite colorimetric assay was performed to determine the GTPase activity of WT and Efl1 mutants. Results: Four patients were homozygous for p.R1095Q variant and two patients were homozygous for p.M882K variant in EFL1 . Residue R1095 and M882 are conserved across species. Neither the GTPase activity of the mutant proteins nor its activation by the SDBD protein or the 60S ribosomal subunit were affected. Complementation of efl1Δ yeast cells with the EFL1 mutants rescued the slow growth phenotype. Nonetheless, Tif6-GFP was relocalised to the cytoplasm in mutant yeast cells in contrast to its nuclear localisation in WT cells. Conclusions: Mutations in EFL1 clinically manifest as SDS-like phenotype. Similar to the molecular pathology of SDS, mutant EFL1 proteins do not promote the release of cytoplasmic Tif6 from the 60S subunit, likely preventing the formation of mature ribosomes.